FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983245397> ?p ?o ?g. }

• W1983245397 endingPage "94" @default.
• W1983245397 startingPage "87" @default.
• W1983245397 abstract "In recent years, with a deeper understanding of pathologic changes in hepatolithiasis, more and more attention has been paid to the relationship of postoperative remnant proliferative cholangitis (PC) with stone recurrence and biliary restenosis, but effective management strategies have not yet been developed. Thus, the aim of this study was to determine whether epidermal growth factor receptor inhibitor (AG-1478) could inhibit hyperplasia and lithogenic potentiality of PC.The PC animal model was established via retrograde insertion of a 5-0 nylon thread into the common bile duct through Vater's papilla. The common bile duct in the therapeutic group received a single intraluminal administration of AG-1478, followed by weekly intraperitoneal injections of AG-1478. Subsequently, influence of EGFR inhibitor on hyperplasia, apoptosis, and lithogenic potential of PC were evaluated via histology, expression changes of EGFR, BrdU, Ki-67, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), Fas, mucin 5 AC, and collagen I.EGFR inhibitor AG-1478 was effective not only in inhibiting the mRNA and protein expression of EGFR, BrdU, and Ki-67, but also in increasing Fas mRNA expression and TUNEL-positive cells, as a result leading to the inhibition of hyperplasia of the biliary epithelium, submucosal gland, and collagen fibers in the diseased bile duct. Additionally, collagen I expression and fibrous thickness of the bile duct wall was significantly reduced, thereby reducing the incidence of biliary tract stricture secondary to PC. Also of note, treatment with AG-1478 could efficiently decrease the lithogenic potential of PC via inhibition of mucin 5AC expression and mucoglycoprotein secretion, hereby facilitating prevention of stone recurrence.EGFR antagonist AG-1478 had a potent anti-proliferative and anti-fibrotic effectiveness on PC and, therefore, holds promise as a candidate of PC treatment." @default.
• W1983245397 created "2016-06-24" @default.
• W1983245397 creator A5012050664 @default.
• W1983245397 creator A5036816780 @default.
• W1983245397 creator A5043673328 @default.
• W1983245397 creator A5049960776 @default.
• W1983245397 creator A5050600087 @default.
• W1983245397 creator A5058146274 @default.
• W1983245397 creator A5068714594 @default.
• W1983245397 creator A5074604141 @default.
• W1983245397 creator A5082878871 @default.
• W1983245397 date "2011-03-01" @default.
• W1983245397 modified "2023-09-23" @default.
• W1983245397 title "Epidermal Growth Factor Receptor as a Target for Anti-Proliferative Treatment of Proliferative Cholangitis in Hepatolithiasis" @default.
• W1983245397 cites W1552458558 @default.
• W1983245397 cites W1966889820 @default.
• W1983245397 cites W1979271536 @default.
• W1983245397 cites W2000255289 @default.
• W1983245397 cites W2000759323 @default.
• W1983245397 cites W2005075550 @default.
• W1983245397 cites W2022813967 @default.
• W1983245397 cites W2032681736 @default.
• W1983245397 cites W2034586060 @default.
• W1983245397 cites W2052816147 @default.
• W1983245397 cites W2057299941 @default.
• W1983245397 cites W2061460535 @default.
• W1983245397 cites W2062008334 @default.
• W1983245397 cites W2065352437 @default.
• W1983245397 cites W2071321746 @default.
• W1983245397 cites W2075129895 @default.
• W1983245397 cites W2087620566 @default.
• W1983245397 cites W2100706096 @default.
• W1983245397 cites W2108388128 @default.
• W1983245397 cites W2113993188 @default.
• W1983245397 cites W2120374931 @default.
• W1983245397 cites W2125245491 @default.
• W1983245397 cites W2135185740 @default.
• W1983245397 cites W2159428872 @default.
• W1983245397 cites W2163846561 @default.
• W1983245397 cites W1988457414 @default.
• W1983245397 doi "https://doi.org/10.1016/j.jss.2009.09.058" @default.
• W1983245397 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20097367" @default.
• W1983245397 hasPublicationYear "2011" @default.
• W1983245397 type Work @default.
• W1983245397 sameAs 1983245397 @default.
• W1983245397 citedByCount "6" @default.
• W1983245397 countsByYear W19832453972013 @default.
• W1983245397 countsByYear W19832453972014 @default.
• W1983245397 countsByYear W19832453972015 @default.
• W1983245397 countsByYear W19832453972016 @default.
• W1983245397 countsByYear W19832453972017 @default.
• W1983245397 countsByYear W19832453972019 @default.
• W1983245397 crossrefType "journal-article" @default.
• W1983245397 hasAuthorship W1983245397A5012050664 @default.
• W1983245397 hasAuthorship W1983245397A5036816780 @default.
• W1983245397 hasAuthorship W1983245397A5043673328 @default.
• W1983245397 hasAuthorship W1983245397A5049960776 @default.
• W1983245397 hasAuthorship W1983245397A5050600087 @default.
• W1983245397 hasAuthorship W1983245397A5058146274 @default.
• W1983245397 hasAuthorship W1983245397A5068714594 @default.
• W1983245397 hasAuthorship W1983245397A5074604141 @default.
• W1983245397 hasAuthorship W1983245397A5082878871 @default.
• W1983245397 hasConcept C126322002 @default.
• W1983245397 hasConcept C141071460 @default.
• W1983245397 hasConcept C142724271 @default.
• W1983245397 hasConcept C159110652 @default.
• W1983245397 hasConcept C170493617 @default.
• W1983245397 hasConcept C179264091 @default.
• W1983245397 hasConcept C196795494 @default.
• W1983245397 hasConcept C204232928 @default.
• W1983245397 hasConcept C2775982439 @default.
• W1983245397 hasConcept C2776909242 @default.
• W1983245397 hasConcept C2777002071 @default.
• W1983245397 hasConcept C2777562237 @default.
• W1983245397 hasConcept C2779438470 @default.
• W1983245397 hasConcept C2779777945 @default.
• W1983245397 hasConcept C502942594 @default.
• W1983245397 hasConcept C71924100 @default.
• W1983245397 hasConcept C90924648 @default.
• W1983245397 hasConceptScore W1983245397C126322002 @default.
• W1983245397 hasConceptScore W1983245397C141071460 @default.
• W1983245397 hasConceptScore W1983245397C142724271 @default.
• W1983245397 hasConceptScore W1983245397C159110652 @default.
• W1983245397 hasConceptScore W1983245397C170493617 @default.
• W1983245397 hasConceptScore W1983245397C179264091 @default.
• W1983245397 hasConceptScore W1983245397C196795494 @default.
• W1983245397 hasConceptScore W1983245397C204232928 @default.
• W1983245397 hasConceptScore W1983245397C2775982439 @default.
• W1983245397 hasConceptScore W1983245397C2776909242 @default.
• W1983245397 hasConceptScore W1983245397C2777002071 @default.
• W1983245397 hasConceptScore W1983245397C2777562237 @default.
• W1983245397 hasConceptScore W1983245397C2779438470 @default.
• W1983245397 hasConceptScore W1983245397C2779777945 @default.
• W1983245397 hasConceptScore W1983245397C502942594 @default.
• W1983245397 hasConceptScore W1983245397C71924100 @default.
• W1983245397 hasConceptScore W1983245397C90924648 @default.
• W1983245397 hasIssue "1" @default.
• W1983245397 hasLocation W19832453971 @default.

• next